Search

Search bills, members, committees and pages...

Sign In

CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)

PreviousNext

13 federal lobbying filings, 2023 to 2026.

CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP) is a client on 13 federal lobbying filings, 2023 to 2026, reporting $420K across them. Coalition to promote lowering prescription drug prices. Based in District of Columbia.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

2 it has hired, by filings.

RegistrantFilingsReported
WHITMER & WORRALL, LLC12$420K
ENDGAME STRATEGIES, LLC1—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20263$100K—
20254$200K—
20244$100K—
20232$20K—

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
CPTCopyright/Patent/Trademark13
MMMMedicare/Medicaid12
PHAPharmacy11
TAXTaxation/Internal Revenue Code3

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 1843To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.6
S. 1032Major Richard Star Act6
S. 1040Drug Competition Enhancement Act6
S. 1041Affordable Prescriptions for Patients Act6
S. 1095Stop STALLING Act6
S. 1096Preserve Access to Affordable Generics and Biosimilars Act6
S. 1097Interagency Patent Coordination and Improvement Act of 20256
S. 229DTC Act of 20256
S. 43Skinny Labels, Big Savings Act6
H.R. 3010No Handouts for Drug Advertisements Act5
H.R. 3152Patent Eligibility Restoration Act of 20255
H.R. 3160PREVAIL Act5
S. 1533A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contr…5
S. 1546Patent Eligibility Restoration Act of 20255
S. 1785No Handouts for Drug Advertisements Act5
S. 1954Biosimilar Red Tape Elimination Act5
H.R. 3269ETHIC Act4
H.R. 3789DTC Act of 20254
H.R. 4570Interagency Patent Coordination and Improvement Act of 20254
H.R. 5526Biosimilar Red Tape Elimination Act4
S. 2276ETHIC Act4
S. 2630Saving NSF’s Workforce Act4
S. 2658Medication Affordability and Patent Integrity Act4
H.R. 1262Mikaela Naylon Give Kids a Chance Act3
H.R. 6485Skinny Labels, Big Savings Act3

Lobbyists

Named on the filings.

LobbyistClientsFilings
ERIK KOMENDANT112
MARTIN WHITMER112
THOMAS WORRALL112
STEVEN DUFFIELD11

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)ENDGAME STRATEGIES, LLC2026 third_quarter—Aug 5, 2026
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2026 second_quarter$50KJul 22, 2026
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2026 first_quarter$50KApr 21, 2026
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2025 fourth_quarter$50KJan 21, 2026
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2025 third_quarter$50KOct 20, 2025
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2025 second_quarter$50KJul 22, 2025
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2025 first_quarter$50KApr 21, 2025
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2024 fourth_quarter$30KFeb 3, 2025
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2024 third_quarter$30KOct 17, 2024
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2024 second_quarter$20KJul 18, 2024
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2024 first_quarter$20KMay 7, 2024
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2023 fourth_quarter$20KJan 18, 2024
CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)WHITMER & WORRALL, LLC2023 fourth_quarter—Dec 4, 2023